nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Quinethazone—SLC12A2—prostate cancer	0.0154	1	CrCbGaD
Polythiazide—SLC12A3—Cation-coupled Chloride cotransporters—SLC12A2—prostate cancer	0.0128	0.452	CbGpPWpGaD
Polythiazide—Hyperglycaemia—Mitoxantrone—prostate cancer	0.00262	0.00274	CcSEcCtD
Polythiazide—Muscle spasms—Conjugated Estrogens—prostate cancer	0.00261	0.00273	CcSEcCtD
Polythiazide—Diarrhoea—Cabazitaxel—prostate cancer	0.00257	0.00268	CcSEcCtD
Polythiazide—Photosensitivity—Capecitabine—prostate cancer	0.00256	0.00268	CcSEcCtD
Polythiazide—Urticaria—Bicalutamide—prostate cancer	0.00256	0.00267	CcSEcCtD
Polythiazide—Vomiting—Degarelix—prostate cancer	0.00253	0.00265	CcSEcCtD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A1—prostate cancer	0.00253	0.0894	CbGpPWpGaD
Polythiazide—Jaundice—Mitoxantrone—prostate cancer	0.00253	0.00264	CcSEcCtD
Polythiazide—Cramp muscle—Etoposide—prostate cancer	0.00252	0.00263	CcSEcCtD
Polythiazide—Vascular purpura—Capecitabine—prostate cancer	0.00252	0.00263	CcSEcCtD
Polythiazide—Rash—Degarelix—prostate cancer	0.00251	0.00262	CcSEcCtD
Polythiazide—Dermatitis—Degarelix—prostate cancer	0.00251	0.00262	CcSEcCtD
Polythiazide—Headache—Degarelix—prostate cancer	0.00249	0.00261	CcSEcCtD
Polythiazide—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00249	0.0026	CcSEcCtD
Polythiazide—Dizziness—Cabazitaxel—prostate cancer	0.00248	0.00259	CcSEcCtD
Polythiazide—Glycosuria—Doxorubicin—prostate cancer	0.00247	0.00258	CcSEcCtD
Polythiazide—Jaundice cholestatic—Epirubicin—prostate cancer	0.00246	0.00257	CcSEcCtD
Polythiazide—Leukopenia—Goserelin—prostate cancer	0.00245	0.00257	CcSEcCtD
Polythiazide—Vertigo—Conjugated Estrogens—prostate cancer	0.00244	0.00255	CcSEcCtD
Polythiazide—Agranulocytosis—Mitoxantrone—prostate cancer	0.00242	0.00253	CcSEcCtD
Polythiazide—Vomiting—Cabazitaxel—prostate cancer	0.00238	0.00249	CcSEcCtD
Polythiazide—Hypersensitivity—Bicalutamide—prostate cancer	0.00237	0.00248	CcSEcCtD
Polythiazide—Nausea—Degarelix—prostate cancer	0.00236	0.00247	CcSEcCtD
Polythiazide—Headache—Cabazitaxel—prostate cancer	0.00235	0.00246	CcSEcCtD
Polythiazide—Purpura—Capecitabine—prostate cancer	0.00233	0.00244	CcSEcCtD
Polythiazide—Hyperuricaemia—Epirubicin—prostate cancer	0.00233	0.00243	CcSEcCtD
Polythiazide—Constipation—Ethinyl Estradiol—prostate cancer	0.00232	0.00243	CcSEcCtD
Polythiazide—Asthenia—Bicalutamide—prostate cancer	0.00231	0.00241	CcSEcCtD
Polythiazide—Jaundice cholestatic—Doxorubicin—prostate cancer	0.00227	0.00238	CcSEcCtD
Polythiazide—Vascular purpura—Prednisone—prostate cancer	0.00224	0.00234	CcSEcCtD
Polythiazide—Nausea—Cabazitaxel—prostate cancer	0.00223	0.00233	CcSEcCtD
Polythiazide—Diarrhoea—Bicalutamide—prostate cancer	0.0022	0.0023	CcSEcCtD
Polythiazide—Blood uric acid increased—Epirubicin—prostate cancer	0.0022	0.0023	CcSEcCtD
Polythiazide—Thrombocytopenia—Goserelin—prostate cancer	0.00219	0.00229	CcSEcCtD
Polythiazide—Urticaria—Ethinyl Estradiol—prostate cancer	0.00216	0.00226	CcSEcCtD
Polythiazide—Hyperuricaemia—Doxorubicin—prostate cancer	0.00215	0.00225	CcSEcCtD
Polythiazide—Anorexia—Goserelin—prostate cancer	0.00213	0.00223	CcSEcCtD
Polythiazide—Dizziness—Bicalutamide—prostate cancer	0.00213	0.00222	CcSEcCtD
Polythiazide—Orthostatic hypotension—Docetaxel—prostate cancer	0.00212	0.00222	CcSEcCtD
Polythiazide—Anorexia—Conjugated Estrogens—prostate cancer	0.00211	0.00221	CcSEcCtD
Polythiazide—Jaundice—Etoposide—prostate cancer	0.0021	0.0022	CcSEcCtD
Polythiazide—Cramp muscle—Docetaxel—prostate cancer	0.00209	0.00219	CcSEcCtD
Polythiazide—Muscle spasms—Estradiol—prostate cancer	0.00209	0.00218	CcSEcCtD
Polythiazide—Purpura—Prednisone—prostate cancer	0.00208	0.00217	CcSEcCtD
Polythiazide—Orthostatic hypotension—Capecitabine—prostate cancer	0.00206	0.00215	CcSEcCtD
Polythiazide—Vomiting—Bicalutamide—prostate cancer	0.00204	0.00214	CcSEcCtD
Polythiazide—Blood uric acid increased—Doxorubicin—prostate cancer	0.00204	0.00213	CcSEcCtD
Polythiazide—Rash—Bicalutamide—prostate cancer	0.00203	0.00212	CcSEcCtD
Polythiazide—Aplastic anaemia—Epirubicin—prostate cancer	0.00203	0.00212	CcSEcCtD
Polythiazide—Dermatitis—Bicalutamide—prostate cancer	0.00203	0.00212	CcSEcCtD
Polythiazide—Headache—Bicalutamide—prostate cancer	0.00201	0.00211	CcSEcCtD
Polythiazide—Agranulocytosis—Etoposide—prostate cancer	0.00201	0.0021	CcSEcCtD
Polythiazide—Paraesthesia—Goserelin—prostate cancer	0.00201	0.0021	CcSEcCtD
Polythiazide—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.002	0.00209	CcSEcCtD
Polythiazide—Agitation—Estradiol—prostate cancer	0.002	0.00209	CcSEcCtD
Polythiazide—Paraesthesia—Conjugated Estrogens—prostate cancer	0.00199	0.00208	CcSEcCtD
Polythiazide—Vertigo—Estradiol—prostate cancer	0.00195	0.00204	CcSEcCtD
Polythiazide—Asthenia—Ethinyl Estradiol—prostate cancer	0.00195	0.00204	CcSEcCtD
Polythiazide—Decreased appetite—Goserelin—prostate cancer	0.00194	0.00203	CcSEcCtD
Polythiazide—Decreased appetite—Conjugated Estrogens—prostate cancer	0.00193	0.00201	CcSEcCtD
Polythiazide—Constipation—Goserelin—prostate cancer	0.00191	0.002	CcSEcCtD
Polythiazide—Nausea—Bicalutamide—prostate cancer	0.00191	0.002	CcSEcCtD
Polythiazide—Constipation—Conjugated Estrogens—prostate cancer	0.0019	0.00198	CcSEcCtD
Polythiazide—Aplastic anaemia—Doxorubicin—prostate cancer	0.00188	0.00196	CcSEcCtD
Polythiazide—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.00186	0.00195	CcSEcCtD
Polythiazide—Leukopenia—Mitoxantrone—prostate cancer	0.00181	0.0019	CcSEcCtD
Polythiazide—Dizziness—Ethinyl Estradiol—prostate cancer	0.0018	0.00188	CcSEcCtD
Polythiazide—Photosensitivity—Epirubicin—prostate cancer	0.00179	0.00187	CcSEcCtD
Polythiazide—Urticaria—Goserelin—prostate cancer	0.00178	0.00186	CcSEcCtD
Polythiazide—Photosensitivity reaction—Capecitabine—prostate cancer	0.00178	0.00186	CcSEcCtD
Polythiazide—Urticaria—Conjugated Estrogens—prostate cancer	0.00176	0.00184	CcSEcCtD
Polythiazide—Hyperglycaemia—Capecitabine—prostate cancer	0.00175	0.00183	CcSEcCtD
Polythiazide—Vascular purpura—Epirubicin—prostate cancer	0.00175	0.00183	CcSEcCtD
Polythiazide—Jaundice—Docetaxel—prostate cancer	0.00175	0.00183	CcSEcCtD
Polythiazide—Vomiting—Ethinyl Estradiol—prostate cancer	0.00173	0.00181	CcSEcCtD
Polythiazide—Rash—Ethinyl Estradiol—prostate cancer	0.00171	0.00179	CcSEcCtD
Polythiazide—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00171	0.00179	CcSEcCtD
Polythiazide—Headache—Ethinyl Estradiol—prostate cancer	0.0017	0.00178	CcSEcCtD
Polythiazide—Pancreatitis—Prednisone—prostate cancer	0.0017	0.00178	CcSEcCtD
Polythiazide—Jaundice—Capecitabine—prostate cancer	0.00169	0.00177	CcSEcCtD
Polythiazide—Agranulocytosis—Docetaxel—prostate cancer	0.00167	0.00175	CcSEcCtD
Polythiazide—Photosensitivity—Doxorubicin—prostate cancer	0.00165	0.00173	CcSEcCtD
Polythiazide—Hypersensitivity—Goserelin—prostate cancer	0.00165	0.00172	CcSEcCtD
Polythiazide—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00163	0.00171	CcSEcCtD
Polythiazide—Purpura—Epirubicin—prostate cancer	0.00163	0.0017	CcSEcCtD
Polythiazide—Vascular purpura—Doxorubicin—prostate cancer	0.00162	0.0017	CcSEcCtD
Polythiazide—Muscle spasms—Etoposide—prostate cancer	0.00162	0.00169	CcSEcCtD
Polythiazide—Agranulocytosis—Capecitabine—prostate cancer	0.00162	0.00169	CcSEcCtD
Polythiazide—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00162	0.00169	CcSEcCtD
Polythiazide—Nausea—Ethinyl Estradiol—prostate cancer	0.00161	0.00169	CcSEcCtD
Polythiazide—Asthenia—Goserelin—prostate cancer	0.00161	0.00168	CcSEcCtD
Polythiazide—Paraesthesia—Estradiol—prostate cancer	0.00159	0.00167	CcSEcCtD
Polythiazide—Asthenia—Conjugated Estrogens—prostate cancer	0.00159	0.00166	CcSEcCtD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—prostate cancer	0.00159	0.0561	CbGpPWpGaD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A4—prostate cancer	0.00159	0.0561	CbGpPWpGaD
Polythiazide—Anorexia—Mitoxantrone—prostate cancer	0.00158	0.00165	CcSEcCtD
Polythiazide—Hyperglycaemia—Prednisone—prostate cancer	0.00156	0.00163	CcSEcCtD
Polythiazide—Decreased appetite—Estradiol—prostate cancer	0.00154	0.00161	CcSEcCtD
Polythiazide—Diarrhoea—Goserelin—prostate cancer	0.00153	0.0016	CcSEcCtD
Polythiazide—Constipation—Estradiol—prostate cancer	0.00152	0.00159	CcSEcCtD
Polythiazide—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00152	0.00159	CcSEcCtD
Polythiazide—Vertigo—Etoposide—prostate cancer	0.00151	0.00158	CcSEcCtD
Polythiazide—Leukopenia—Etoposide—prostate cancer	0.00151	0.00158	CcSEcCtD
Polythiazide—Purpura—Doxorubicin—prostate cancer	0.00151	0.00157	CcSEcCtD
Polythiazide—Paraesthesia—Mitoxantrone—prostate cancer	0.00148	0.00155	CcSEcCtD
Polythiazide—Dizziness—Goserelin—prostate cancer	0.00148	0.00155	CcSEcCtD
Polythiazide—Dizziness—Conjugated Estrogens—prostate cancer	0.00147	0.00153	CcSEcCtD
Polythiazide—Decreased appetite—Mitoxantrone—prostate cancer	0.00144	0.0015	CcSEcCtD
Polythiazide—Orthostatic hypotension—Epirubicin—prostate cancer	0.00143	0.0015	CcSEcCtD
Polythiazide—Vomiting—Goserelin—prostate cancer	0.00142	0.00149	CcSEcCtD
Polythiazide—Constipation—Mitoxantrone—prostate cancer	0.00141	0.00148	CcSEcCtD
Polythiazide—Rash—Goserelin—prostate cancer	0.00141	0.00148	CcSEcCtD
Polythiazide—Dermatitis—Goserelin—prostate cancer	0.00141	0.00147	CcSEcCtD
Polythiazide—Vomiting—Conjugated Estrogens—prostate cancer	0.00141	0.00147	CcSEcCtD
Polythiazide—Urticaria—Estradiol—prostate cancer	0.00141	0.00147	CcSEcCtD
Polythiazide—Headache—Goserelin—prostate cancer	0.0014	0.00147	CcSEcCtD
Polythiazide—Rash—Conjugated Estrogens—prostate cancer	0.0014	0.00146	CcSEcCtD
Polythiazide—Dermatitis—Conjugated Estrogens—prostate cancer	0.0014	0.00146	CcSEcCtD
Polythiazide—Headache—Conjugated Estrogens—prostate cancer	0.00139	0.00145	CcSEcCtD
Polythiazide—Thrombocytopenia—Etoposide—prostate cancer	0.00135	0.00141	CcSEcCtD
Polythiazide—Muscle spasms—Docetaxel—prostate cancer	0.00135	0.00141	CcSEcCtD
Polythiazide—Nausea—Goserelin—prostate cancer	0.00133	0.00139	CcSEcCtD
Polythiazide—Pancreatitis—Epirubicin—prostate cancer	0.00133	0.00139	CcSEcCtD
Polythiazide—Orthostatic hypotension—Doxorubicin—prostate cancer	0.00132	0.00139	CcSEcCtD
Polythiazide—Nausea—Conjugated Estrogens—prostate cancer	0.00132	0.00138	CcSEcCtD
Polythiazide—Urticaria—Mitoxantrone—prostate cancer	0.00131	0.00137	CcSEcCtD
Polythiazide—Anorexia—Etoposide—prostate cancer	0.00131	0.00137	CcSEcCtD
Polythiazide—Hypersensitivity—Estradiol—prostate cancer	0.00131	0.00137	CcSEcCtD
Polythiazide—Muscle spasms—Capecitabine—prostate cancer	0.0013	0.00136	CcSEcCtD
Polythiazide—Asthenia—Estradiol—prostate cancer	0.00127	0.00133	CcSEcCtD
Polythiazide—Leukopenia—Docetaxel—prostate cancer	0.00125	0.00131	CcSEcCtD
Polythiazide—Photosensitivity reaction—Epirubicin—prostate cancer	0.00124	0.00129	CcSEcCtD
Polythiazide—Paraesthesia—Etoposide—prostate cancer	0.00123	0.00129	CcSEcCtD
Polythiazide—Pancreatitis—Doxorubicin—prostate cancer	0.00123	0.00129	CcSEcCtD
Polythiazide—Hyperglycaemia—Epirubicin—prostate cancer	0.00122	0.00128	CcSEcCtD
Polythiazide—Vertigo—Capecitabine—prostate cancer	0.00122	0.00127	CcSEcCtD
Polythiazide—Hypersensitivity—Mitoxantrone—prostate cancer	0.00122	0.00127	CcSEcCtD
Polythiazide—Diarrhoea—Estradiol—prostate cancer	0.00121	0.00127	CcSEcCtD
Polythiazide—Leukopenia—Capecitabine—prostate cancer	0.00121	0.00127	CcSEcCtD
Polythiazide—Decreased appetite—Etoposide—prostate cancer	0.00119	0.00125	CcSEcCtD
Polythiazide—Asthenia—Mitoxantrone—prostate cancer	0.00119	0.00124	CcSEcCtD
Polythiazide—Jaundice—Epirubicin—prostate cancer	0.00118	0.00123	CcSEcCtD
Polythiazide—Constipation—Etoposide—prostate cancer	0.00118	0.00123	CcSEcCtD
Polythiazide—Dizziness—Estradiol—prostate cancer	0.00117	0.00123	CcSEcCtD
Polythiazide—Photosensitivity reaction—Doxorubicin—prostate cancer	0.00114	0.0012	CcSEcCtD
Polythiazide—Hyperglycaemia—Doxorubicin—prostate cancer	0.00113	0.00118	CcSEcCtD
Polythiazide—Diarrhoea—Mitoxantrone—prostate cancer	0.00113	0.00118	CcSEcCtD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.00113	0.0399	CbGpPWpGaD
Polythiazide—Vomiting—Estradiol—prostate cancer	0.00113	0.00118	CcSEcCtD
Polythiazide—Agranulocytosis—Epirubicin—prostate cancer	0.00113	0.00118	CcSEcCtD
Polythiazide—Thrombocytopenia—Docetaxel—prostate cancer	0.00112	0.00117	CcSEcCtD
Polythiazide—Rash—Estradiol—prostate cancer	0.00112	0.00117	CcSEcCtD
Polythiazide—Dermatitis—Estradiol—prostate cancer	0.00112	0.00117	CcSEcCtD
Polythiazide—Headache—Estradiol—prostate cancer	0.00111	0.00116	CcSEcCtD
Polythiazide—Agitation—Prednisone—prostate cancer	0.00111	0.00116	CcSEcCtD
Polythiazide—Urticaria—Etoposide—prostate cancer	0.00109	0.00114	CcSEcCtD
Polythiazide—Jaundice—Doxorubicin—prostate cancer	0.00109	0.00114	CcSEcCtD
Polythiazide—Anorexia—Docetaxel—prostate cancer	0.00109	0.00114	CcSEcCtD
Polythiazide—Vertigo—Prednisone—prostate cancer	0.00108	0.00113	CcSEcCtD
Polythiazide—Thrombocytopenia—Capecitabine—prostate cancer	0.00108	0.00113	CcSEcCtD
Polythiazide—Anorexia—Capecitabine—prostate cancer	0.00105	0.0011	CcSEcCtD
Polythiazide—Nausea—Estradiol—prostate cancer	0.00105	0.0011	CcSEcCtD
Polythiazide—Vomiting—Mitoxantrone—prostate cancer	0.00105	0.0011	CcSEcCtD
Polythiazide—Agranulocytosis—Doxorubicin—prostate cancer	0.00104	0.00109	CcSEcCtD
Polythiazide—Rash—Mitoxantrone—prostate cancer	0.00104	0.00109	CcSEcCtD
Polythiazide—Dermatitis—Mitoxantrone—prostate cancer	0.00104	0.00109	CcSEcCtD
Polythiazide—Headache—Mitoxantrone—prostate cancer	0.00104	0.00108	CcSEcCtD
Polythiazide—Paraesthesia—Docetaxel—prostate cancer	0.00103	0.00107	CcSEcCtD
Polythiazide—Hypersensitivity—Etoposide—prostate cancer	0.00101	0.00106	CcSEcCtD
Polythiazide—Paraesthesia—Capecitabine—prostate cancer	0.000993	0.00104	CcSEcCtD
Polythiazide—Decreased appetite—Docetaxel—prostate cancer	0.000993	0.00104	CcSEcCtD
Polythiazide—Asthenia—Etoposide—prostate cancer	0.000986	0.00103	CcSEcCtD
Polythiazide—Nausea—Mitoxantrone—prostate cancer	0.000982	0.00103	CcSEcCtD
Polythiazide—Constipation—Docetaxel—prostate cancer	0.000977	0.00102	CcSEcCtD
Polythiazide—Decreased appetite—Capecitabine—prostate cancer	0.000962	0.00101	CcSEcCtD
Polythiazide—Constipation—Capecitabine—prostate cancer	0.000946	0.000989	CcSEcCtD
Polythiazide—Diarrhoea—Etoposide—prostate cancer	0.000941	0.000984	CcSEcCtD
Polythiazide—Anorexia—Prednisone—prostate cancer	0.000939	0.000982	CcSEcCtD
Polythiazide—Dizziness—Etoposide—prostate cancer	0.000909	0.000951	CcSEcCtD
Polythiazide—Muscle spasms—Epirubicin—prostate cancer	0.000908	0.000949	CcSEcCtD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000893	0.0316	CbGpPWpGaD
Polythiazide—Paraesthesia—Prednisone—prostate cancer	0.000885	0.000925	CcSEcCtD
Polythiazide—Urticaria—Capecitabine—prostate cancer	0.000879	0.000919	CcSEcCtD
Polythiazide—Vomiting—Etoposide—prostate cancer	0.000874	0.000914	CcSEcCtD
Polythiazide—Agitation—Epirubicin—prostate cancer	0.000868	0.000907	CcSEcCtD
Polythiazide—Rash—Etoposide—prostate cancer	0.000867	0.000906	CcSEcCtD
Polythiazide—Dermatitis—Etoposide—prostate cancer	0.000866	0.000906	CcSEcCtD
Polythiazide—Headache—Etoposide—prostate cancer	0.000861	0.000901	CcSEcCtD
Polythiazide—Decreased appetite—Prednisone—prostate cancer	0.000856	0.000896	CcSEcCtD
Polythiazide—Vertigo—Epirubicin—prostate cancer	0.000848	0.000887	CcSEcCtD
Polythiazide—Leukopenia—Epirubicin—prostate cancer	0.000845	0.000884	CcSEcCtD
Polythiazide—Constipation—Prednisone—prostate cancer	0.000843	0.000881	CcSEcCtD
Polythiazide—Hypersensitivity—Docetaxel—prostate cancer	0.000842	0.00088	CcSEcCtD
Polythiazide—Muscle spasms—Doxorubicin—prostate cancer	0.00084	0.000878	CcSEcCtD
Polythiazide—Asthenia—Docetaxel—prostate cancer	0.00082	0.000857	CcSEcCtD
Polythiazide—Nausea—Etoposide—prostate cancer	0.000817	0.000854	CcSEcCtD
Polythiazide—Hypersensitivity—Capecitabine—prostate cancer	0.000815	0.000852	CcSEcCtD
Polythiazide—Agitation—Doxorubicin—prostate cancer	0.000803	0.00084	CcSEcCtD
Polythiazide—Asthenia—Capecitabine—prostate cancer	0.000794	0.00083	CcSEcCtD
Polythiazide—Vertigo—Doxorubicin—prostate cancer	0.000785	0.000821	CcSEcCtD
Polythiazide—Urticaria—Prednisone—prostate cancer	0.000783	0.000818	CcSEcCtD
Polythiazide—Leukopenia—Doxorubicin—prostate cancer	0.000782	0.000818	CcSEcCtD
Polythiazide—Diarrhoea—Docetaxel—prostate cancer	0.000782	0.000817	CcSEcCtD
Polythiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—prostate cancer	0.000766	0.0271	CbGpPWpGaD
Polythiazide—Diarrhoea—Capecitabine—prostate cancer	0.000757	0.000791	CcSEcCtD
Polythiazide—Dizziness—Docetaxel—prostate cancer	0.000755	0.00079	CcSEcCtD
Polythiazide—Thrombocytopenia—Epirubicin—prostate cancer	0.000754	0.000789	CcSEcCtD
Polythiazide—Anorexia—Epirubicin—prostate cancer	0.000735	0.000768	CcSEcCtD
Polythiazide—Dizziness—Capecitabine—prostate cancer	0.000731	0.000765	CcSEcCtD
Polythiazide—Vomiting—Docetaxel—prostate cancer	0.000726	0.00076	CcSEcCtD
Polythiazide—Hypersensitivity—Prednisone—prostate cancer	0.000726	0.000759	CcSEcCtD
Polythiazide—Rash—Docetaxel—prostate cancer	0.00072	0.000753	CcSEcCtD
Polythiazide—Dermatitis—Docetaxel—prostate cancer	0.00072	0.000753	CcSEcCtD
Polythiazide—Headache—Docetaxel—prostate cancer	0.000716	0.000748	CcSEcCtD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000709	0.0251	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000709	0.0251	CbGpPWpGaD
Polythiazide—Asthenia—Prednisone—prostate cancer	0.000707	0.000739	CcSEcCtD
Polythiazide—Vomiting—Capecitabine—prostate cancer	0.000703	0.000735	CcSEcCtD
Polythiazide—Thrombocytopenia—Doxorubicin—prostate cancer	0.000698	0.00073	CcSEcCtD
Polythiazide—Rash—Capecitabine—prostate cancer	0.000697	0.000729	CcSEcCtD
Polythiazide—Dermatitis—Capecitabine—prostate cancer	0.000697	0.000729	CcSEcCtD
Polythiazide—Headache—Capecitabine—prostate cancer	0.000693	0.000725	CcSEcCtD
Polythiazide—Paraesthesia—Epirubicin—prostate cancer	0.000692	0.000724	CcSEcCtD
Polythiazide—Anorexia—Doxorubicin—prostate cancer	0.00068	0.000711	CcSEcCtD
Polythiazide—Nausea—Docetaxel—prostate cancer	0.000679	0.00071	CcSEcCtD
Polythiazide—Diarrhoea—Prednisone—prostate cancer	0.000674	0.000705	CcSEcCtD
Polythiazide—Decreased appetite—Epirubicin—prostate cancer	0.00067	0.0007	CcSEcCtD
Polythiazide—Constipation—Epirubicin—prostate cancer	0.000659	0.000689	CcSEcCtD
Polythiazide—Nausea—Capecitabine—prostate cancer	0.000657	0.000687	CcSEcCtD
Polythiazide—Dizziness—Prednisone—prostate cancer	0.000652	0.000681	CcSEcCtD
Polythiazide—Paraesthesia—Doxorubicin—prostate cancer	0.00064	0.000669	CcSEcCtD
Polythiazide—Vomiting—Prednisone—prostate cancer	0.000626	0.000655	CcSEcCtD
Polythiazide—Rash—Prednisone—prostate cancer	0.000621	0.00065	CcSEcCtD
Polythiazide—Dermatitis—Prednisone—prostate cancer	0.000621	0.000649	CcSEcCtD
Polythiazide—Decreased appetite—Doxorubicin—prostate cancer	0.00062	0.000648	CcSEcCtD
Polythiazide—Headache—Prednisone—prostate cancer	0.000617	0.000645	CcSEcCtD
Polythiazide—Urticaria—Epirubicin—prostate cancer	0.000612	0.00064	CcSEcCtD
Polythiazide—Constipation—Doxorubicin—prostate cancer	0.00061	0.000638	CcSEcCtD
Polythiazide—Nausea—Prednisone—prostate cancer	0.000585	0.000612	CcSEcCtD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000575	0.0203	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000574	0.0203	CbGpPWpGaD
Polythiazide—Hypersensitivity—Epirubicin—prostate cancer	0.000568	0.000594	CcSEcCtD
Polythiazide—Urticaria—Doxorubicin—prostate cancer	0.000566	0.000592	CcSEcCtD
Polythiazide—Asthenia—Epirubicin—prostate cancer	0.000553	0.000578	CcSEcCtD
Polythiazide—Diarrhoea—Epirubicin—prostate cancer	0.000527	0.000551	CcSEcCtD
Polythiazide—Hypersensitivity—Doxorubicin—prostate cancer	0.000525	0.000549	CcSEcCtD
Polythiazide—Asthenia—Doxorubicin—prostate cancer	0.000512	0.000535	CcSEcCtD
Polythiazide—Dizziness—Epirubicin—prostate cancer	0.00051	0.000533	CcSEcCtD
Polythiazide—Vomiting—Epirubicin—prostate cancer	0.00049	0.000512	CcSEcCtD
Polythiazide—Diarrhoea—Doxorubicin—prostate cancer	0.000488	0.00051	CcSEcCtD
Polythiazide—Rash—Epirubicin—prostate cancer	0.000486	0.000508	CcSEcCtD
Polythiazide—Dermatitis—Epirubicin—prostate cancer	0.000485	0.000508	CcSEcCtD
Polythiazide—Headache—Epirubicin—prostate cancer	0.000483	0.000505	CcSEcCtD
Polythiazide—Dizziness—Doxorubicin—prostate cancer	0.000471	0.000493	CcSEcCtD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	0.000469	0.0166	CbGpPWpGaD
Polythiazide—Nausea—Epirubicin—prostate cancer	0.000458	0.000479	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.000454	0.016	CbGpPWpGaD
Polythiazide—Vomiting—Doxorubicin—prostate cancer	0.000453	0.000474	CcSEcCtD
Polythiazide—Rash—Doxorubicin—prostate cancer	0.00045	0.00047	CcSEcCtD
Polythiazide—Dermatitis—Doxorubicin—prostate cancer	0.000449	0.00047	CcSEcCtD
Polythiazide—Headache—Doxorubicin—prostate cancer	0.000447	0.000467	CcSEcCtD
Polythiazide—Nausea—Doxorubicin—prostate cancer	0.000424	0.000443	CcSEcCtD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00037	0.0131	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00036	0.0127	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00036	0.0127	CbGpPWpGaD
Polythiazide—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	0.000342	0.0121	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000292	0.0103	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.00027	0.00954	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000238	0.00843	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000227	0.00802	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000193	0.00683	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000182	0.00645	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000174	0.00615	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000154	0.00543	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000146	0.00517	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000112	0.00395	CbGpPWpGaD
Polythiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	8.86e-05	0.00313	CbGpPWpGaD
